Purchase Order HHSN261201700607P

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on July 30, 2020, with an ultimate completion date of August 31, 2020. The order procures scientific equipment on a firm fixed price basis. Performance occurs at Nexcelom's facility in Lawrence, Massachusetts. No set-aside category was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $14,955.00 on September 3, 2019, for lab equipment. The order carries no set-aside designation. Performance is located in Lawrence, Massachusetts, with an ultimate completion date of September 30, 2019. The purchase order is priced on a firm fixed price basis for commercial laboratory equipment, including cell analysis and imaging cytometry products used in biomedical research.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on September 14, 2020, for scientific equipment on a firm fixed price basis. Performance will occur in Lawrence, Massachusetts, with an ultimate completion date of November 11, 2020. No small business set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,955.00 on November 21, 2019, for a maintenance agreement with an ultimate completion date of December 14, 2020. Performance will take place in Bethesda, Maryland. The contract carries no small business set-aside and is priced on a firm fixed-price basis.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on May 4, 2018, with performance completion on May 3, 2019. No set-aside was used. Work is performed in Lawrence, Massachusetts. The order is for firm fixed price and covers scientific equipment and related supplies for cell analysis in biomedical research applications.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC on July 19, 2018, with a ceiling value of $12,280.00. Performance is located in Lawrence, Massachusetts. The order is firm fixed price with no small business set-aside applied. Ultimate completion is scheduled for August 18, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $139,000.00 on September 5, 2018, for acquisition of a Nexcelom Bioscience Celigo Imaging Cytometer. Place of performance is Lawrence, Massachusetts. The order carries no set-aside designation and has a firm fixed price. Ultimate completion date is October 3, 2018. The award derives from a pre-solicitation posted August 9, 2018, with a due date of August 24, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $24,732.00 on July 17, 2020, for scientific equipment. Performance occurs in Lawrence, Massachusetts. The order uses firm fixed price and carries no small business set-aside. Ultimate completion is August 15, 2020.</p>

<p>The National Cancer Institute issued a purchase order to Nexcelom Bioscience LLC valued at $12,955.00 on December 4, 2019, for a maintenance agreement with an ultimate completion date of December 5, 2020. Performance is located in Lawrence, Massachusetts. The order carries no set-aside designation and employs firm fixed-price pricing.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,955.00 on May 31, 2018, for a maintenance agreement, with ultimate completion May 31, 2019. Performance occurs in Lawrence, Massachusetts. The order is firm fixed price with no set-aside applied.</p>